Narcolepsy Global Clinical Trials Review, H2, 2012

GlobalData, August 2012, Pages: 86

Narcolepsy Global Clinical Trials Review, H2, 2012

Summary

Our clinical trial report, “Narcolepsy Global Clinical Trials Review, H2, 2012" provides data on the Narcolepsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Narcolepsy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Narcolepsy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Narcolepsy Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Narcolepsy, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

List of Tables
List of Figures
Introduction
Narcolepsy
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Narcolepsy
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Narcolepsy Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Cephalon, Inc.
Clinical Trial Overview of Cephalon, Inc.
Orphan Medical, Inc. (Inactive)
Clinical Trial Overview of Orphan Medical, Inc. (Inactive)
UCB S.A.
Clinical Trial Overview of UCB S.A.
BIOPROJET PHARMA SARL
Clinical Trial Overview of BIOPROJET PHARMA SARL
BIOPROJET SCR
Clinical Trial Overview of BIOPROJET SCR
Aerial BioPharma LLC
Clinical Trial Overview of Aerial BioPharma LLC
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Johnson & Johnson
Clinical Trial Overview of Johnson & Johnson
Orasi Medical, Inc.
Clinical Trial Overview of Orasi Medical, Inc.
Arena Pharmaceuticals, Inc.
Clinical Trial Overview of Arena Pharmaceuticals, Inc.
Sun Pharmaceutical Industries Limited
Clinical Trial Overview of Sun Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Limited
Clinical Trial Overview of Teva Pharmaceutical Industries Limited
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Mylan Inc.
Clinical Trial Overview of Mylan Inc.
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Emory University
Clinical Trial Overview of Emory University
University of Arkansas
Clinical Trial Overview of University of Arkansas
Zentrum fur Integrative Psychiatrie
Clinical Trial Overview of Zentrum fur Integrative Psychiatrie
Brigham and Women's Hospital
Clinical Trial Overview of Brigham and Women's Hospital
Neuropsychiatric Research Institute
Clinical Trial Overview of Neuropsychiatric Research Institute
Hopital du Sacre-Coeur de Montreal
Clinical Trial Overview of Hopital du Sacre-Coeur de Montreal
National Taiwan University Hospital
Clinical Trial Overview of National Taiwan University Hospital
University Hospital, Bordeaux
Clinical Trial Overview of University Hospital, Bordeaux
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About Us
Contact Us
Disclaimer
Source

List of Tables
Narcolepsy Therapeutics Market, Global, Clinical Trials by Zone, 2012-
Narcolepsy Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Narcolepsy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Narcolepsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012-
Narcolepsy Therapeutics Clinical Trials, Europe, Top Five Countries, 2012-
Narcolepsy Therapeutics Clinical Trials, North America, Top Countries, 2012-
Narcolepsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012-
Narcolepsy Therapeutics Clinical Trials, Central and South America, Top Countries, 2012-
Narcolepsy Therapeutics Clinical Trials, BRIC Countries, 2012-
Narcolepsy Therapeutics Clinical Trials, G7 Countries, 2012-
Narcolepsy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Narcolepsy Therapeutics Clinical Trials, E7 Countries, 2012-
Narcolepsy Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012-
Narcolepsy Therapeutics Market, Global, Clinical Trials by Phase, 2012-
Narcolepsy Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012-
Narcolepsy Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Narcolepsy Therapeutics Market, Global, Terminated Clinical Trials, 2012-
Narcolepsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Narcolepsy Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Narcolepsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Narcolepsy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Orphan Medical, Inc. (Inactive), 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by BIOPROJET PHARMA SARL, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by BIOPROJET SCR, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Aerial BioPharma LLC, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Orasi Medical, Inc., 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Arena Pharmaceuticals, Inc., 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Inc., 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Arkansas, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Zentrum fur Integrative Psychiatrie, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Neuropsychiatric Research Institute, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hopital du Sacre-Coeur de Montreal, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2012-
Narcolepsy Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2012-

List of Figures
Narcolepsy Therapeutics Market, Global, Clinical Trials by Zone (%), 2012-
Narcolepsy Therapeutics Market, Global, Clinical Trials by Top Countries, 2012-
Narcolepsy Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012-
Narcolepsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012-
Narcolepsy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012-
Narcolepsy Therapeutics Clinical Trials, North America, Top Countries (%), 2012-
Narcolepsy Therapeutics Clinical Trials, BRIC Countries (%), 2012-
Narcolepsy Therapeutics Clinical Trials, G7 Countries (%), 2012-
Narcolepsy Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012-
Narcolepsy Therapeutics Clinical Trials, E7 Countries (%), 2012-
Narcolepsy Therapeutics Market, Global, Clinical Trials by Phase (%), 2012-
Narcolepsy Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012-
Narcolepsy Therapeutics Market, Global, Clinical Trials by Trial Status, 2012-
Narcolepsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011
Narcolepsy Therapeutics Clinical Trials, Global, Key Sponsors, 2012-
Narcolepsy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012-
Narcolepsy Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012-
GlobalData Methodology

Customers who bought this item also bought

• Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019
• Cholangitis Global Clinical Trials Review, H1, 2013
• Strabismus Global Clinical Trials Review, H1, 2013
• Nasal Congestion Global Clinical Trials Review, H1, 2013
• Bronchitis Global Clinical Trials Review, H2, 2012
• Ulcers Global Clinical Trials Review, H1, 2013
• Otitis Media Global Clinical Trials Review, H2, 2012
• Cachexia Global Clinical Trials Review, H1, 2013
• Alopecia Global Clinical Trials Review, H1, 2013
• Hemostasis Global Clinical Trials Review, H1, 2013